학술논문

During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ
Document Type
article
Source
EBioMedicine. 2(9)
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Immunology
HIV/AIDS
Genetics
Clinical Research
Infectious Diseases
Infection
Adult
Antiretroviral Therapy
Highly Active
CD8-Positive T-Lymphocytes
DNA
Viral
Female
HIV-1
HLA-DP Antigens
HLA-DQ Antigens
HLA-DR Antigens
Humans
Linear Models
Male
Middle Aged
Multivariate Analysis
Viral Load
Suppression
Reservoir
Persistence
Integration
Activation
ERAS Study Group
2-LTR
2-long terminal repeats
ART
Anti-retroviral therapy
CMV
cytomegalovirus virus
CRN
Clinical Research Network
EBV
Epstein-Bar virus
ELISA
enzyme-linked immune-enzymatic assay
HIC
HIV-1 controllers
HIV-1 VL
HIV-1 viral load
HIV-1
Human Immunodeficiency Virus type 1
HLA
Human Leukocyte Antigen
LPS
lipopolysaccharide
NIHR
National Institute for Health Research
NNRTI
Non-nucleoside reverse-transcriptase inhibitors
NRTI
nucleoside/nucleotide reverse transcriptase inhibitors
PBMCs
Peripheral blood mononuclear cells
PCR
Polymerase chain reaction
PFA
paraformaldehyde
VLS
Viral Load Suppression
WHO
World Health Organisation
sCD14
soluble CD14
Clinical Sciences
Public Health and Health Services
Clinical sciences
Epidemiology
Language
Abstract
BackgroundCharacterising the correlates of HIV persistence improves understanding of disease pathogenesis and guides the design of curative strategies. This study investigated factors associated with integrated HIV-1 DNA load during consistently suppressive first-line antiretroviral therapy (ART).MethodTotal, integrated, and 2-long terminal repeats (LTR) circular HIV-1 DNA, residual plasma HIV-1 RNA, T-cell activation markers, and soluble CD14 (sCD14) were measured in peripheral blood of 50 patients that had received 1-14 years of efavirenz-based or nevirapine-based therapy.ResultsIntegrated HIV-1 DNA load (per 10(6) peripheral blood mononuclear cells) was median 1.9 log10 copies (interquartile range 1.7-2.2) and showed a mean difference of 0.2 log10 copies per 10 years of suppressive ART (95% confidence interval - 0.2, 0.6; p = 0.28). It was positively correlated with total HIV-1 DNA load and frequency of CD8(+)HLA-DR/DP/DQ(+) cells, and was also higher in subjects with higher sCD14 levels, but showed no correlation with levels of 2-LTR circular HIV-1 DNA and residual plasma HIV-1 RNA, or the frequency of CD4(+)CD38(+) and CD8(+)CD38(+) cells. Adjusting for pre-ART viral load, duration of suppressive ART, CD4 cell counts, residual plasma HIV-1 RNA levels, and sCD14 levels, integrated HIV-1 DNA load was mean 0.5 log10 copies higher for each 50% higher frequency of CD8(+)HLA-DR/DP/DQ(+) cells (95% confidence interval 0.2, 0.9; p = 0.01).ConclusionsThe observed positive association between integrated HIV-1 DNA load and frequency of CD8(+)DR/DP/DQ(+) cells indicates that a close correlation between HIV persistence and immune activation continues during consistently suppressive therapy. The inducers of the distinct activation profile warrant further investigation.